Transgene Market Cap

Transgene has a market cap or net worth of €81.54 million as of April 28, 2025. Its market cap has decreased by -45.21% in one year.

Market Cap

81.54M

Enterprise Value

75.26M

Revenue

6.35M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.62

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 81.54M, a decrease of -46.31%. That is a compound annual growth rate of -2.27%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	81.54M	-9.16%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	137.90M	6.95%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EssilorLuxottica Société anonyme	115.68B
Sanofi	113.05B
Sartorius Stedim Biotech	19.58B
bioMérieux	13.62B
Eurofins Scientific SE	9.75B
Ipsen	8.03B
Virbac	2.52B
emeis Société anonyme	1.66B

Market Cap Rankings